Clinical Trial Update: Trial Evaluating the Safety of 2 Schedules of Cabazitaxel in Elderly Men With mCRPC Previously Treated With a Docetaxel [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating two cabazitaxel dosing schedules in elderly men with metastatic prostate cancer previously treated with docetaxel has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Cabazitaxel (cabazitaxel)

Snippet

Sponsor: Association Pour La Recherche des Thérapeutiques Innovantes en Cancérologie | Conditions: Prostate Cancer Metastatic | Phase 3 | Status: COMPLETED